You may like to download the latest version of Flash
Market data
Top weekly gains and losses
Cardtronics: 10.376
ICAP: -20.797

 

 
21 February 2008 - 14:51

Reed Elsevier to buy US insurance data firm ChoicePoint for $4.1bn

Publisher Reed Elsevier plans to integrate ChoicePoint with its LexisNexis Risk Information and Analytics Group to create a risk management business with $1.5 billion in revenues.

More than 50% of ChoicePoint's $982 million revenue and 80% of its business operating income from continuing operations in 2007 came from insurance sector. It said earlier this month that it had further boosted its insurance industry focus with the acquisition of Australian firm Optimal Decisions Group (ODG), which specialises in advanced analytics and software for the insurance industry.

In a statement, Reed Elsevier says the combination of ChoicePoint's data and analytics assets with LexisNexis technology will create greater opportunities in addressing the growing risk information and analytics needs in insurance, financial, legal, screening, law enforcement, public safety, healthcare and other sectors.

The all-cash deal, which will be funded by $600 million in new debt, is expected to be accretive to adjusted earnings from the first year. It is expected to deliver a post-tax return on capital in excess of Reed Elsevier's cost of capital by the third year, with returns continuing to climb thereafter.

The deal has received unanimous recommendation of the ChoicePoint board, but is subject to ChoicePoint shareholder and regulatory approvals.

Separately, Reed Elsevier disclosed plans to divest its Reed Business Information division and says it will be looking at various options in the coming months.


 
  Comments

 
No comments. Be the first to comment on this now (membership required)

  Related blog posts

 

 
  Related news

 

 

 

 

 

 

 
  Related company news

 
  
 

 
Most discussed blogs
 
Featured job
Find your next job!
search 
 
Most viewed - last 10 days

 

 

 
Editorial: news@finextra.com   Sales and member queries: contact@finextra.com   © Finextra Research 2010